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BIOKOMPOSIT HIDROKSIAPATIT DENGAN PENGUAT ZIRKONIA 
UNTUK PENINGKATAN KEKUATAN DAN KELIATAN 
 
ABSTRAK 
 
Biokomposit zirkonia/hidroksiapatit (ZrO2/HAp) telah dihasilkan dengan 
objektif untuk meningkatkan kekuatan patah dan keliatan patah bioseramik HAp 
monilitik. Y2O3-ZrO2 komersil dan CaO-ZrO2 disintesis telah dipillih sebagai bahan 
penguat di dalam matrik HAp. Kaedah pemprosesan seramik yang lazim, 
termasuklah pencampuran, penekanan dan pensinteran, telah digunakan untuk 
menghasilkan sampel ZrO2/HAp. Pada mulanya, HAp yang diperkuatkan dengan 
nisbah berbeza ZrO2 komersil (5, 10, 15 dan 20% berat) telah dihasilkan 
menggunakan penekan isostatik sejuk (CIP) dan kemudiannya disinter pada suhu 
1050°C hingga 1250°C dalam persekitaran udara selama 5 jam. Keputusan 
menunjukkan sifat fizikal dan mekanikal merosot dengan penambahan Y2O3-ZrO2 
yang lebih tinggi. Nilai kekuatan patah dan keliatan patah adalah 73 MPa dan 0.85 
MPa.m1/2 untuk sampel 5% berat Y2O3-ZrO2/HAP. Ini berpunca daripada penguraian 
HAp ke β-TCP. Bagi meningkatkan keupayaan pensinteran dan kestabilan fasa 
biokomposit ini, sedikit CaF2 telah ditambahkan. Penambahan CaF2 didapati mampu 
mengekalkan fasa HAp dan menghadkan penukarannya kepada β-TCP. Kekuatan 
patah dan keliatan patah optimum untuk 20% berat Y2O3-ZrO2 dengan 5% berat 
CaF2 adalah 126 MPa dan 1.9 MPa.m1/2 manakala bagi 5% berat Y2O3-ZrO2 dengan 
5% berat CaF2 nilainya adalah 151 MPa dan 1.4 MPa.m1/2. Pada masa sama, kaedah 
penguraian polimer telah digunakan untuk mensintesis serbuk tetragonal CaO-ZrO2 
bersaiz nano. Kajian awal menunjukkan penambahan CaO-ZrO2 mampu 
meningkatkan kekuatan dan keliatan HAp berbanding penambahan Y2O3-ZrO2. Nilai 
diperolehi adalah lebih tinggi berbanding sifat optimum HAp monolitik. 
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ZIRCONIA REINFORCED HYDROXYAPATITE BIOCOMPOSITE FOR 
STRENGTH AND TOUGHNESS IMPROVEMENT 
 
ABSTRACT 
 
Zirconia/hydroxyapatite (ZrO2/HAp) biocomposites were fabricated with the 
objective to improve the strength and fracture toughness of monolithic HAp 
bioceramics. Commercial Y2O3-ZrO2 and synthesized CaO-ZrO2 were selected as the 
reinforcement material for the HAp matrix. Conventional ceramic processing route 
was used to prepare the samples of ZrO2/HAp, which involved mixing, compaction 
and sintering. Initially HAp reinforced with different ratios of commercial Y2O3-
ZrO2 (5, 10, 15 and 20 wt%)  were compacted by using cold isostatic press (CIP) and 
subsequently sintered from 1050°C to 1250°C in air atmosphere for 5 hours. The 
results show that the physical and mechanical properties had deteriorated with higher 
amount of Y2O3-ZrO2. The value in fracture strength and toughness was 73 MPa and 
0.85 MPa.m1/2 for the sample 5 wt% Y2O3-ZrO2/HAP. This was due to 
decomposition of HAp to β-TCP. To improve sinterability and the phase stability of 
these biocomposites, small amounts of CaF2 were added. Addition of CaF2 was able 
to retain the HAp phase, limiting its transformation to β-TCP. The optimum flexural 
strength and fracture toughness values for 20 wt% Y2O3-ZrO2 with 5 wt% CaF2 
addition was 126 MPa and 1.9 MPa.m1/2, respectively while that for 5 wt% Y2O3-
ZrO2 and 5 wt% CaF2, the values were 151 MPa and 1.4 MPa.m1/2. At the same time, 
a polymer precursor decomposition method was adopted to synthesize nanosized 
tetragonal CaO-ZrO2. Preliminary study with the incorporation of synthesized CaO-
ZrO2 without CaF2 was found to be effective to improve the strength and toughness 
of the HAp as compared with addition of Y2O3-ZrO2. The values obtained were 
relatively higher than the optimum properties of monolithic HAp. 
1 
 
CHAPTER 1 
INTRODUCTION 
 
1.1 Background and Problem Statement 
Hydroxyapatite (HAp), a very important bioceramic, has been studied and 
used extensively in medical applications for repair or replacement of bone tissues in 
human body system. With the chemical formula Ca10(PO4)6(OH)2, hydroxyapatite is 
chemically similar to the mineral component of bone and teeth, and it will form an 
artificial bone-like structure with the surrounding bone tissue when implanted 
[Hench and Wilson, 1993].  The reason for using hydroxyapatite as a bone substitute 
material is because natural bone is approximately 70% hydroxyapatite by weight and 
50% hydroxyapatite by volume [Shackelford, 1999]. 
 
HAp is frequently used for reconstruction and replacement of damaged bone 
or tooth zones in plastic and dental surgeries as well as in coatings on dental and 
orthopedic implants [Muster, 1992].  Metals coated with hydroxyapatite have also 
been introduced as artificial bones. The hydroxyapatite coating will help the 
surrounding tissue to bond firmly with the implant while the metal provides the 
strength for the artificial bone [Oonishi, 1991].  
 
 
2 
 
Hydroxyapatite is reported to have a calcium to phosphate ratio of 1.67:1, and 
is relatively insoluble, thus suitable for prosthetic applications [Akao et. al., 1981]. It 
has consistent bioactive properties and therefore is well suited as a calcium 
phosphate coating for total joint arthoplasty and total knee arthoplasty. HAp has also 
been shown to be biocompatible, nontoxic, and capable of bonding directly to bone, 
thus allowing for true osteointegration [Søballe and Friedman, 1996; Epinette, 1999]. 
 
However, sintered hydroxyapatite material exhibits relatively poor 
mechanical properties than natural bone. For instance, it has a low fracture toughness 
value, low strength and high brittleness. The fracture toughness (KIc) of the HAp 
ceramics does not exceed the value of about 1 MPa.m1/2 as compared with 2-12 
MPa.m1/2 for human bone [Suchanek et. al., 1997; Qing-Liang et. al, 2004]. Because 
of these disadvantages, HAp are not viable as heavy-loaded implants. Their medical 
applications are limited to small unloaded implants, coatings and low loaded porous 
implants. 
 
For full utilization of bioactive HAp based implants, the improvement of 
mechanical properties are necessary. One of the possible methods to improve these 
properties can be by the incorporation of reinforcing phases into HAp, i.e. as a 
composite. The addition of bioinert materials such as alumina (Al2O3) was found to 
improve the mechanical properties of hydroxyapatite [Champion et. al., 1996; 
Gautier et. al., 1996]. However, other researchers have found that adding Al2O3, an 
amphoteric material, had encouraged reaction with the HAp, forming tricalcium 
3 
 
phosphate and calcium aluminate and thereby reducing the mechanical properties 
[Ahmad Fauzi and Saud, 2004]. 
 
Other candidate material for the reinforcing phase for HAp is zirconia (ZrO2) 
[Rapacz Kmita et. al., 2006]. Zirconia-based materials exhibit exceptional toughness 
due to martensitic transformation of tetragonal (t) to monoclinic ZrO2 (m) (t → m). 
Medical applications of ZrO2 implants confirmed their satisfactory biocompatibility, 
although it cannot bond well to bone tissue. Nevertheless, it is also considered as a 
bioinert material [Park and Bronzino, 2003]. 
 
Zirconia is a well-known polymorph that occurs in three forms: monoclinic 
(m), tetragonal (t) and cubic (c). Pure zirconia is monoclinic at room temperature. 
This phase is stable up to 1170°C. Above this temperature it transforms into 
tetragonal and then into cubic phase above 2370°C. During cooling, a t → m 
transformation takes place in a temperature range of about 100°C below 1070°C. The 
phase transformation taking place while cooling is associated with a volume 
expansion of approximately 3-4%. Stresses generated by the expansion originate 
cracks in pure zirconia ceramics that, after sintering in the range 1500-1700°C, will 
break catastrophically into pieces at room temperature [Porter and Heuer, 1977; 
Piconi and Maccauro, 1999]. 
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However, the addition of stabilizing oxides, like CaO, MgO, CeO2 or Y2O3, 
to pure ZrO2 allows generation of multiphase materials typically referred as Partially 
Stabilized Zirconia (PSZ), whose microstructure at room temperature generally 
consists of cubic zirconia with tetragonal zirconia precipitates. The precipitates may 
exist at grain boundaries or within the cubic matrix grains. The mechanical strength 
of PSZ was improved by a homogeneous and fine distribution of the tetragonal phase 
within the cubic matrix [Green et. al., 1989]. 
 
The tetragonal metastable precipitates finely dispersed within the cubic 
matrix were able to be transformed into the monoclinic phase when the constraint 
exerted on them by the matrix was relieved, i.e. by a crack advancing in the material. 
In that case, the stress field associated with expansion due to the phase 
transformation acts in opposition to the stress field that promotes the propagation of 
the crack. Enhancement in toughness will be obtained, because the energy associated 
with crack propagation is dissipated both in the t → m transformation and in 
overcoming the compression stresses due to the volume expansion. 
 
With this background, this research was conducted to investigate the 
possibility of the improvement of HAp mechanical properties by using partially 
stabilized zirconia as the reinforcing phases. The transformation toughening 
mechanism in zirconia was expected to occur and thus improve the fracture 
toughness of HAp. The stability of the phases also needs to be studied carefully to 
maintain the biocompatibility of the system.  Therefore, in this research, work was 
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focused to optimize the strength and fracture toughness of the reinforced 
hydroxyapatite biocomposite. 
 
1.2 Objective of the Research 
The objective of this research is to develop hydroxyapatite biocomposite with 
improved fracture toughness and strength with good physical properties and 
biocompatibility. With this main objective, the following studies were conducted: 
1. Preparation of ZrO2/HAp biocomposite bodies by conventional ceramic 
processing technique and characterizing the physical and mechanical properties. 
Commercial Y2O3-ZrO2 and synthesized CaO-ZrO2 were used as the reinforcing 
material. 
2. Investigation of the bioactivity of Y2O3-ZrO2/HAp biocomposite using simulated 
body fluid (SBF). 
 
1.3 Project Overview 
In this study, the conventional ceramic processing technique which involved 
wet mixing and dry pressing were selected. This technique was selected due to the 
simple process, low production cost, equipment availability and also easily 
adjustable parameters. Various parameters were investigated in preparing the 
ZrO2/HAp biocomposite. The amount of ZrO2 addition was varied in order to study 
the optimum composition of ZrO2/HAp biocomposite. The sintering process was 
conducted in several different temperatures to investigate the most favorable 
sintering temperature to achieve optimum properties of the ZrO2/HAp biocomposite 
which are comparable with human bone properties. The effect of ZrO2 addition and 
sintering temperature to the phase stability of the HAp was also studied. Two types 
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of zirconia, i.e. commercial Y2O3-ZrO2 and synthesized CaO-ZrO2, were used in this 
study. The influences of both type of ZrO2 were analyzed in this study. 
 
The prepared ZrO2/HAp biocomposite samples were characterized using X-
Ray diffraction (XRD) for phase identification and scanning electron microscope 
(SEM) for topography and morphology analysis. The density and the shrinkage of 
the samples were measured, and the mechanical properties of the composite were 
determined by using Vickers hardness test and three point bending test. 
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CHAPTER 2 
LITERATURE REVIEW 
 
2.0 Introduction 
Biomaterials are widely used to make devices to replace a part or a function 
of the body in a safe and biocompatible manner. The development and applications 
of biomaterials have been continually expanded since the first vanadium steel plates 
were introduced in 1912 by W.D. Sherman to help in the fixation of bone fractures 
[Park and Bronzino, 2003]. Over the years, various definitions of the term 
biomaterials have been proposed. Black (1999) defined biomaterials as materials 
intended to interface with biological systems to evaluate, treat or replace any tissues, 
organ, or function of the body. Other definition have simply defined biomaterials as 
synthetic materials used to make devices to replace part of a living system or to 
function in intimate contact with living tissue [Park, 2000]. 
 
Hydroxyapatite (HAp) is one of biomaterials that have received large 
attention due to its chemical composition which is similar to that of the mineral 
constituent of bone [Shackelford, 1999]. Bioactive properties of HAp allow the 
formation of tissue and bone-like layer on its surface hence encourages better 
fixation of implants [Chen et. al., 2002]. Therefore, many studies are continuously 
being carried out to investigate the properties of HAp and to expand its applications 
in wider usage as orthopedic implants. 
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This review starts with an overview about the structure and properties of bone 
tissue. Bioceramic materials will be described in more detail starting with its 
classifications and applications. Then the properties of HAp and other calcium 
phosphate materials are also the presented thoroughly in this chapter. This is 
followed by a review on ceramic biocomposite concept and explanation on the role 
of zirconia as a candidate for reinforcement phase for HAp. At the end, some 
evaluation techniques on the biological performance of materials are briefly 
explained. 
 
2.1 Bone Tissue 
Most bioceramics implants are in contact with bone, and therefore it is 
necessary to understand the characteristic of bone. Bone is a living material 
composed of cells and a blood supply covered by a strong, interwoven composite 
structure [Hench and Wilson, 1993]. Each bone organ is made up of bone tissue with 
cartilage tissue, other connective tissue and nerves. The major roles of bone are to 
serve as a support for the body’s muscles, protection for some parts of the body, and 
also act as a reserve of calcium for the body [Krajewski and Ravaglioli, 1991]. 
 
2.1.1 Composition of Bone Tissue 
Bone tissue is a composite made of 60 to 70% mineral substances and 30 to 
40% organic tissues. This ratio holds true although the properties of a bone varies 
from point to point, and the ratio of the substances in the skeleton also differ from 
one bone organ to another [Krajewski and Ravaglioli, 1991]. The composition of 
bone depends on a large number of factors, e.g., species, age, sex, type of bone tissue 
and the location from which the sample is taken [Katz, 2000]. However, in general 
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there are three major components of bone tissue, and they are [Hench and Wilson, 
1993]: 
1. Collagen, which is flexible and very tough 
2. Biological apatites, bone mineral, which is the reinforcing phase of the 
composite 
3. Bone matrix or ground substance, which performs various cellular support 
functions. 
 
 Collagen is a natural, polymeric protein and the most important structural 
material in vertebratas. Collagen constitutes 36% of bone by weight, and the form of 
collagen found in bone is termed Type I. It is the dominant form throughout the body 
[Shackleford, 1999]. Collagen, which can be considered as the matrix of bone, is a 
triple helix structure and each strand being made up sequences of amino acids 
[Meyers et. al., 2008]. Some data for the composition of adult human and bovine 
cortical bone are given in Table 2.1. 
 
Table 2.1 Composition of adult human and bovine cortical bone [Katz, 2000] 
Species % H2O % Apatite % Dry weight collagen 
Bovine 9.1 76.4 21.5 
Human 7.3 67.2 21.2 
 
Biological apatites, which are the mineral phases of bone tissue, are usually 
referred to as calcium hydroxyapatite, although biological apatites are usually 
calcium deficient and carbonate substituted [LeGeros and LeGeros, 1993; Landi et. 
al., 2003]. Small amounts of magnesium, fluoride, carbonate, chloride and potassium 
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are also found in the mineral substance of bone. Table 2.2 shows the comparative 
composition of human enamel and bone. 
 
Table 2.2: Enamel and bone component of the human adult [LeGeros and LeGeros, 
1993] 
Constituent Enamel Bone 
Calcium, Ca2+ 36.0 24.5 
Phosphorus, P 17.7 11.5 
Ca/P molar ratio 1.62 1.65 
Sodium, Na+ 0.5 0.7 
Potassium, K+ 0.08 0.03 
Magnesium, Mg2+ 0.44 0.55 
Carbonate, CO32- 3.2 5.8 
Fluoride, F- 0.01 0.02 
Chloride. Cl- 0.30 0.10 
Total inorganic 97.0 65.0 
Total organic 1.0 25.0 
Absorbed H2O 1.5 9.7 
 
2.1.2 Structure and Properties of Bone Tissue 
The complexity of bone’s properties comes from the complexity of its 
structure [Katz, 2000]. Therefore it is important to understand the bone structure in 
order to analyze the properties. There are two principal types of bone, i.e. cancellous 
bone and cortical bone. Cancellous bone, also called trabecular or spongy bone, is 
less dense than cortical bone (compact bone). Cortical bone is found in long bones 
(femur, tibia, fibula), while cancellous bone is found in the core of bones, in flat 
bones and occurs across the ends of the long bones [Meyers et. al., 2008]. 
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Figure 2.1: Longitudinal section of a human femur [Meyers et. al., 2008]  
 
Figure 2.1 shows the structure of a long bone. The surface regions consist of 
cortical bone, while the inside is porous and is called cancellous bone. The porosity 
reduces the strength of the bone, but also reduces their weight. Bones are shaped in 
such a manner that strength is provided only where it is needed. The porosity of 
cancellous bone provides interesting mechanical properties. Table 2.3 gives some 
information about mechanical properties of bone tissues. The mechanical strength is 
determined by the porosity and the manner in which the porosity is structured, 
therefore cortical bone have higher strength compared to cancellous bone. 
Cancellous bone has a lower modulus of elasticity and higher strain to failure than 
cortical bone and this is due to its lower density. The pores also perform other 
physiological functions and contain the marrow [Meyers et. al., 2008].  
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Table 2.3: Mechanical properties of bone tissues [Hench and Wilson, 1993] 
Property Cortical Bone Cancellous Bone 
Compressive Strength 
(MPa) 
100-230 2-12 
Flexural Strength (MPa) 
 
50-150 10-20 
Strain to failure 
 
1-3 5-7 
Young’s Modulus 
(GPa) 
7-30 0.5-0.05 
Fracture Toughness, KIC 
(MPa.m1/2) 
2-12 N.A. 
 
The variation of the properties values of the bone tissue is dependent upon 
age, location of the bone and direction of measurement. The maximum compressive 
strength of cortical bone is around 200 MPa, and it will show a progressive loss of 
strength with age. Figure 2.2 illustrates that the increase in age would lead to a 
decrease in strength. Hence, elderly people will have higher risk of bone fracture 
when they fall. 
 
 
Figure 2.2: Effect of age on strength of bone [Hench and Wilson, 1993] 
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2.2 Ceramics and Bioceramics Implants 
Ceramic is defined as the art and science of making and using solid articles 
that have as their essential component being inorganic nonmetallic materials 
[Kingery et. al., 1976]. Ceramics are refractory, polycrystalline compounds, usually 
inorganic, including silicates, metallic oxides, carbides, nitrides, and various 
refractory hydrides and sulfides. 
 
Unlike metals and polymers, ceramics are difficult to shear plastically due to 
the ionic nature of the bonding and the minimum number of slip systems. Ceramics 
are nonductile materials and are generally hard. Ceramics are very susceptible to 
microcracks because, instead of undergoing plastic deformation, they will fracture 
elastically on initiation of crack. At the crack tip the stress could be many times 
higher than the stress in the material. Other characteristics of ceramic materials are 
their high melting temperatures and low conductivity of electricity and heat. These 
characteristic are due to the chemical bonding within the ceramics [Park and Lakes, 
1992]. 
 
During the last couple of decades, ceramics has been use to improve the 
quality of human life. Innovative techniques for fabricating ceramics have led to their 
use as advance materials. Specially designed and fabricated ceramics for the repair 
and reconstruction of diseased, damaged or worn out parts of the body are widely 
developed. Ceramics used for the purpose to improve the quality of human life are 
called bioceramics. Most clinical applications of bioceramics are related to the repair 
of the skeletal tissues, composed of bones, joints and teeth, and to augment both hard 
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and soft tissues. Ceramic are also used to replace parts of the cardiovascular system, 
especially heart valves [Hench and Wilson, 1993].  
 
In order to be classified as a bioceramic, the ceramic material must meet or 
exceed the following desired properties of implantable bioceramics [Bilotte, 2003], 
that is they should be: 
1. Nontoxic  
2. Noncarsinogenic  
3. Nonallergic  
4. Noninflammatory  
5. Biocompatible  
6. Biofunctional for its lifetime in the host 
 
Although bioceramics seem to be a suitable candidate for implant materials, 
the natural problem in conventional ceramics are also the challenge that inhibits the 
application of bioceramics. Primary drawbacks of bioceramics are their brittleness, 
high Young modulus, and inferior workability. Brittleness becomes a significant 
problem when bioceramics are used in positions with high stress loading. Stress 
shielding is observed when bone tissue is bonded with materials with high Young’s 
modulus, where the bone around the materials is resorbed [Ishikawa et. al., 2003]. 
Because the bioceramics workability is not good, it is difficult for the surgeon to 
shape the bioceramics when necessary during the surgery [Shackelford, 1999]. 
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2.2.1 Classification of Bioceramics 
Bioceramics can be classified independently in terms of their behavior in the 
body environment. Such a classification method is especially useful and relevant 
since bioceramics are used in human body. This method classifies bioceramics as 
relatively bioinert or nonabsorbable, bioactive or surface reactive, and biodegradable 
or bioresorbable ceramics [Bilotte, 2003]. It is also critical that any bioceramics 
implant avoid a toxic response that kills cells in the surrounding tissues and can 
cause systemic damage to the patient [Hench and Wilson, 1993]. 
 
The fundamental principle in the classification of bioceramics is based on 
chemical reactivity with the physiological environment. Bioinert ceramic, such as 
alumina (Al2O3), have a tendency to exhibit inherently low levels of reactivity which 
peak on the order of 104 day (over 250 days). Bioactive ceramics have a 
substantially higher level of reactivity peaking on the order of 100 days, while 
bioresorbable ceramics have even higher levels of reactivity peaking on the order of 
10 days as shown in Figure 2.3 [Hench, 1991].  
 
 
Figure 2.3: Bioactivity spectrum for various bioceramics implants [Hench, 1991]. 
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2.2.1.1 Bioinert ceramics 
Bioinert ceramics are defined as ceramics that are stable in human body and 
do not show harmful response or bioactivity. Bioinert ceramics maintain their 
physical and mechanical properties while in the host [Bilotte, 2003]. In general, the 
living body recognizes artificial materials as foreign materials when the latter are 
implanted in the living body and consequently the artificial materials are covered 
with fibrous layer.  The thickness of fibrous layer depends on the tissue compatibility 
of the implanted materials. Biologically inactive, nearly inert ceramics (like alumina 
and zirconia) will elicit thin fibrous capsule at their interface, while metals and most 
polymers may cause a total encapsulation of the implant within the fibrous layer. For 
an implant made of bioinert materials, a tight mechanical fit with the host tissue is 
very important in order to prevent interfacial movement and subsequent clinical 
failure [Hench and Wilson, 1993]. 
 
Example of relatively bioinert ceramics are dense and porous alumina, 
zirconia ceramics, and a single-phase calcium aluminates. Bioinert ceramics are 
usually applied as structural support implants, such as bone plates, bone screws, and 
femoral heads. Examples of a non-structural support uses are ventilation tubes, 
sterilization devices, and drug delivery devices [Bilotte, 2003]. 
 
2.2.1.2 Bioresorbable Ceramics 
Bioresorbable or biodegradable ceramics degrades upon implantation in the 
host. The resorbed material is replaced by endogeneous tissues. Instead of replacing 
the tissues, the material encourages the regeneration of tissues to take their place, and 
the degradation rate varies from material to material. Examples of bioresorbable 
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ceramics are aluminum calcium phosphate, coralline, plaster of paris, and beta-
tricalcium phosphate (β-TCP) [Bilotte, 2003].  
 
There are a few issues or criteria that need to be taken into consideration in 
order to successfully implant the bioresorbable ceramics. The constituent of the 
materials need to be of a composition that can be broken down chemically by body 
fluids. The degradation products must also be non-toxic chemical compounds that 
can be easily disposed of without damaging the surrounding cells or harming the 
host’s health. Moreover, the resorption rate of the materials must also match the 
restoration rate of the tissues even as the material provides a sufficient mechanical 
strength to support the host tissue while the regeneration of tissues takes place 
[Hench and Wilson, 1993]. 
  
2.2.1.3 Bioactive ceramics 
Bioactive ceramics are defined as the material that bond directly with bone 
without having fibrous connective tissues between them. Upon implantation in the 
host, bioactive ceramics form a strong bond with adjacent tissue. This characteristic 
of direct bonding is extremely useful, especially when the biomaterial is used in an 
area where the material will be bonded with bone. 
 
In order for an implant to perform optimally, its properties, such as a 
controlled rate of chemical reactivity, morphology and phase composition need to be 
carefully engineered according to its function and rate of bonding to the host tissue. 
A small change in composition can change the properties of the bioceramics from 
nearly inert to bioresorbable to bioactive. In bioactive ceramics, unlike bioresorbable 
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ceramics, chemical reactions only occur at the surface while the rest of the implant 
remains largely stable [Hench and Wilson, 1993] 
 
Examples of bioactive ceramics are dense porous glasses, Bioglass and 
Ceravital, and hydroxyapatites. One of their many applications is the coating of 
metal prostheses. This coating provides a stronger bonding to the adjacent tissues, 
which is very important for prostheses [Bilotte, 2003]. It is still not fully explained 
why bioactive ceramics bond directly with bone. One hypothesis is that apatite shows 
good osteoconductivity since it is an excellent adsorbent, and thus adsorbs necessary 
factors including the adhesion factor that is required for the wandering osteoblast 
[Ishikawa et. al., 2003]. 
 
2.2.2 Applications of Bioceramics 
Bioceramics are produced in a variety of forms and phases and serve many 
different functions in repair of the body. These are summarized in Figure 2.4. In 
many applications, bioceramics are used in the form of bulk of a specific shape 
called implants, prostheses, or prosthetic devices. Bioceramics are also used to fill 
space while the natural repair processes restore function. In other applications, 
bioceramics are used as coating on a substrate, or a second phase in a composite, 
combining the characteristics of both materials into a new material with enhanced 
mechanical and biochemical properties [Hench and Wilson, 1993]. 
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Figure 2.4: Clinical uses of bioceramics [Hench and Wilson, 1993]. 
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2.3 Calcium Phosphate (CaP) Bioceramics 
Calcium phosphate (CaP) has been synthesized and used for manufacturing 
various forms of implants, as well as for solid coatings on other implants. There are 
several forms of calcium phosphate and they typically form a wide group of 
compounds called apatite. It is said that an Australian mineral researcher Werner 
named a mineral as apatite in 1786 based on the Greek word “apataw”, which means 
puzzled, since it was confused with several other similar looking minerals. 
 
Calcium phosphate bioceramics include hydroxyapatite from synthetic, 
natural (from coral) and biological (from bovine bone) origin, calcium-deficient 
apatite (CDA), tricalcium phosphate (β-TCP), biphasic calcium phosphate (BCP) and 
calcium phosphate cements consisting of mixtures of different CaP phases, e.g., β-
TCP, tetracalcium phosphate (TTCP), monocalcium phosphate monohydrate 
(MCPM), dicalcium phosphate dehydrate (DCPD or brushite), dicalcium phosphate 
anhydrous (DCPA or monetite) and octacalcium phosphate (OCP) [LeGeros and 
LeGeros, 1996]. 
 
The types of calcium phosphate phase formed depend on the Ca/P ratio, 
presence of water, impurities and temperature [Hench, 1998]. For example, 
hydroxyapatite is more likely to form in a wet environment and at lower temperature 
(<900oC), while in a dry atmosphere and at higher temperature, β-TCP will be 
formed [Park and Lakes, 1992]. Table 2.4 gives the summary of various calcium 
phosphate ceramics and their Ca/P ratio. 
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Table 2.4: Calcium phosphate ceramics and their applications [LeGeros and 
LeGeros, 2003] 
Calcium Phosphate Ca/P Applications 
Monocalcium phosphate monohydrate, 
MCPM 
Ca(H2PO4)2 
0.5 Cements, polyphosphates 
Dicalcium phosphate dehydrate, DCPD 
CaHPO4.2H2O 
1.0 Cements, coating 
Dicalcium phosphate anhydrous, 
DCPA 
CaHPO4 
1.0 Cements, coating 
Octacalcium phosphate, OCP 
Ca8H2(PO4)6. 5H2O 
1.33 Coatings, bonegraft 
Alpha tricalcium phosphate, α-TCP 
Ca3(PO4)2 
1.50 Cements 
Beta-tricalcium phosphate, β-TCP 
Ca3(PO4)2 
1.50 
Cements, bonegraft 
composites 
Calcium-deficient apatite, CDA 
Ca3(PO4)2 
<1.67 
Bonegraft, cements, 
composites 
Hydroxyapatite, HA 
Ca10(PO4)6(OH)2 
1.67 Bonegraft, coatings 
Biphasic calcium phosphate, BCP 
HA/β-TCP 
1.55-1.66 Bonegraft, coatings 
Fluorapatite, FA 
Ca10(PO4)6F2 
1.67 Bonegraft, coating 
Carbonate hydroxyapatite 
(Ca,Na)10(PO4,CO3)6(OH)2 
1.7-2.6 Bonegraft 
Tetracalcium phosphate, TTCP 
Ca(PO4)2O 
2.0 Cements 
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2.3.1 Hydroxyapatite 
Hydroxyapatite (HAp) is the dominant inorganic component if the hard tissue 
of the human body, such as dental and bone, and it represent the bioactive ceramics. 
The term hydroxyapatite is used generally to represent Ca10(PO4)6(OH)2 in the field 
of biomaterials, although the term apatite originally indicates a much wider 
composition [Shackelford, 1999].  
 
Although the term HAp with the stoichiometric chemical formula, 
Ca10(PO4)6(OH)2, are used generally for simplicity, apatite found in enamel, dentin, 
and bone show more complex composition [Ishikawa et. al., 2003]. In spite of a large 
variety of compositions, calcium hydroxyapatite belongs to the hexagonal system, 
with a P63/m space group. The unit cell contains a complete representation of the 
apatite crystal, consisting of Ca2+, PO43-, and OH- groups closely packed together in 
arrangement shown in Figure 2.5. The substitute ion of OH- with fluoride gives HAp 
greater chemical stability due to the closer coordination of fluoride (symmetric 
shape) as compared to hydroxyl (asymmetric) by the nearest calcium. This is why 
fluoridation of drinking water helps in resisting caries of the teeth [Park and Lakes, 
1992]. 
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Figure 2.5: The atomic arrangement of calcium hydroxyapatite                            
[Hench and Wilson, 1993].  
 
The theoretical composition of pure HAp is 39.68 wt% Ca and 18.45 wt% P 
with Ca/P molar ratio of 1.667. In dense HAp material, variations in Ca/P ratios after 
sintering are reflecting the β-TCP/HAp ratios which in turn reflect the purity. If the 
Ca/P is 1.67, only HAp will be observed in the X-ray diffraction. If the Ca/P ratio is 
lower than 1.67, β-TCP and other phases such as tetracalcium phosphate (TTCP) will 
be present with the HAp phase, depending on the temperature and condition of 
sintering. If Ca/P is higher than 1.67, CaO will be present with the HAp phase 
[Hench and Wilson, 1993]. 
 
2.3.1.1 Hydroxyapatite as an implant materials 
Its similarity to the inorganic phases of bone and teeth makes hydroxyapatite 
a very attractive candidate for implant materials. Hydroxyapatite is often used as 
bone substitute because of its superior biocompatibility, showing a capacity for direct 
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chemical bonding with bone [Muster, 1992]. Hydroxyapatite is not resorbed in the 
human body upon implantation and will stay in the human body while positively 
influencing bone formation and thus speeding up recovery [Ishikawa et. al., 2003]. 
 
Hydroxyapatite is often used as coatings on metallic implants, usually 
titanium, titanium alloys, and stainless steels, due to its surface reactivity. The body 
responds to metallic implants by surrounding it with fibrous tissues in order to isolate 
it. The coating of HAp provide a bioactive surface which allows the implant to bond 
with the bone tissues while retaining the mechanical properties of the metal within 
[Oonishi, 1991, Lim et. al., 1999]. Hydroxyapatite is also commonly applied as filler 
materials and scaffolds for bone reconstruction. The need for these fillers occur when 
there is a bone loss due to diseases or accident or when bone augmentations or 
replacement of fragments on non-loaded bones are required, such as ridge 
augmentations, ear implants and repair of periodontal defects [Muster, 1992]. 
Hydroxyapatite acts as a frame or scaffold that facilitates the growth of tissues across 
the void. It is readily incorporated into the bone structure even as it encourages bone 
growth and speeds up the healing process [Akao et. al., 1981].  
 
2.3.1.2 Mechanical properties and manufacturing techniques of hydroxyapatite 
In order to fabricate HAp bioceramic implants with desired shapes and 
properties, researchers investigates the use of conventional and advanced ceramic 
manufacturing techniques. The techniques used to fabricate HAp will depend on the 
application of the implants and the desired properties. For applications as hard tissue 
replacement, the most important and immediate property is the strength since the 
